BRPI0410021A - preparação farmacêutica sólida, que contém sais levotiroxina e/ou liotironina como substáncia ativa - Google Patents

preparação farmacêutica sólida, que contém sais levotiroxina e/ou liotironina como substáncia ativa

Info

Publication number
BRPI0410021A
BRPI0410021A BRPI0410021-2A BRPI0410021A BRPI0410021A BR PI0410021 A BRPI0410021 A BR PI0410021A BR PI0410021 A BRPI0410021 A BR PI0410021A BR PI0410021 A BRPI0410021 A BR PI0410021A
Authority
BR
Brazil
Prior art keywords
pharmaceutical preparation
salts
preparation containing
lyothyronine
solid pharmaceutical
Prior art date
Application number
BRPI0410021-2A
Other languages
English (en)
Inventor
Walter Burghart
Kurt Burghart
Johannes Raneburger
Original Assignee
Globopharm Pharmazeutische Pro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33314944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0410021(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Globopharm Pharmazeutische Pro filed Critical Globopharm Pharmazeutische Pro
Publication of BRPI0410021A publication Critical patent/BRPI0410021A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PREPARAçãO FARMACêUTICA SóLIDA, QUE CONTéM SAIS LEVOTIROXINA E/OU LIOTIRONINA COMO SUBSTáNCIA ATIVA". Em uma preparação farmacêutica, que contém sais solúveis em água de levotiroxina e/ou liotironina como substância ativa, a atividade de água da preparação farmacêutica, medida à temperatura ambiente, está ajustada para valores abaixo de 0,4, preferivelmente, 0,1 a 0,3.
BRPI0410021-2A 2003-05-02 2004-05-03 preparação farmacêutica sólida, que contém sais levotiroxina e/ou liotironina como substáncia ativa BRPI0410021A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT6672003 2003-05-02
PCT/AT2004/000150 WO2004096177A1 (de) 2003-05-02 2004-05-03 Feste pharmazeutische zubereitung enthaltend levothyroxin- und/oder liothyroninsalze

Publications (1)

Publication Number Publication Date
BRPI0410021A true BRPI0410021A (pt) 2006-04-25

Family

ID=33314944

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410021-2A BRPI0410021A (pt) 2003-05-02 2004-05-03 preparação farmacêutica sólida, que contém sais levotiroxina e/ou liotironina como substáncia ativa

Country Status (13)

Country Link
EP (1) EP1622587B1 (pt)
JP (1) JP5414146B2 (pt)
AT (1) ATE465718T1 (pt)
AU (1) AU2004234176B2 (pt)
BR (1) BRPI0410021A (pt)
CA (1) CA2523079C (pt)
DE (1) DE502004011103D1 (pt)
DK (1) DK1622587T3 (pt)
ES (1) ES2344294T3 (pt)
PT (1) PT1622587E (pt)
RU (1) RU2361573C2 (pt)
WO (1) WO2004096177A1 (pt)
ZA (1) ZA200509026B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
US20100119601A1 (en) * 2007-04-11 2010-05-13 Pharmaceutical Productions Inc. Melatonin tablet and methods of preparation and use
PE20150597A1 (es) * 2012-08-20 2015-05-06 Merck Patent Gmbh Preparacion farmaceutica solida que contiene levotiroxina

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
DE19541128C2 (de) * 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
US5635209A (en) * 1995-10-31 1997-06-03 Vintage Pharmaceuticals, Inc. Stabilized composition of levothyroxine sodium medication and method for its production
EP0861073B1 (en) * 1995-11-14 2004-07-28 Abbott GmbH & Co. KG Stabilized thyroid hormone preparations and methods of making same
JP2001114712A (ja) * 1996-04-16 2001-04-24 Takeda Chem Ind Ltd Ｄ−マンニトールおよびその製造法
DE19653410A1 (de) * 1996-12-20 1998-06-25 Basf Ag Verwendung von Carotinoid-Solubilisaten zum Färben von Lebensmitteln und pharmazeutischen Zubereitungen
JP2001516365A (ja) * 1997-11-17 2001-09-25 ギスト ブロカデス ベスローテン フェンノートシャップ クラブラネート及び１種以上の賦形剤を含む顆粒
JP3274416B2 (ja) * 1998-05-29 2002-04-15 佐藤製薬株式会社 口腔内崩壊性粒状製剤
FR2781793B1 (fr) 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
JP2000060535A (ja) * 1998-08-21 2000-02-29 Kyowa Hakko Kogyo Co Ltd 微生物菌体の保存方法
JP3491887B2 (ja) * 1999-04-28 2004-01-26 フロイント産業株式会社 糖アルコール造粒物集合体の製法
GB9919487D0 (en) * 1999-08-17 1999-10-20 Nestle Sa Moulded onfectionery product comprising vegetables
JP4677084B2 (ja) * 1999-09-30 2011-04-27 武田薬品工業株式会社 塩酸ブロムヘキシンを含有する固形製剤
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
CN1211382C (zh) * 2000-06-30 2005-07-20 葛兰素集团有限公司 喹唑啉二甲苯磺酸盐化合物
ES2174734B1 (es) * 2000-11-03 2003-10-01 Belmac S A Lab Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
BR0207297A (pt) * 2001-02-15 2005-04-19 King Pharmaceuticals Inc Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
JP4291962B2 (ja) * 2001-03-27 2009-07-08 あすか製薬株式会社 安定な甲状腺ホルモン含有固形製剤組成物
PL369972A1 (en) 2002-01-07 2005-05-02 Abbott Gmbh & Co.Kg Crystallization of amino acids using ultrasonic agitation

Also Published As

Publication number Publication date
RU2005137577A (ru) 2006-05-10
CA2523079A1 (en) 2004-11-11
CA2523079C (en) 2012-08-14
RU2361573C2 (ru) 2009-07-20
EP1622587B1 (de) 2010-04-28
PT1622587E (pt) 2010-07-07
JP5414146B2 (ja) 2014-02-12
JP2006525234A (ja) 2006-11-09
ES2344294T3 (es) 2010-08-24
DK1622587T3 (da) 2010-08-23
EP1622587A1 (de) 2006-02-08
WO2004096177A1 (de) 2004-11-11
ZA200509026B (en) 2007-03-28
AU2004234176B2 (en) 2010-05-13
DE502004011103D1 (de) 2010-06-10
AU2004234176A1 (en) 2004-11-11
ATE465718T1 (de) 2010-05-15

Similar Documents

Publication Publication Date Title
ATE362314T1 (de) Herbizidzusammensetzungen umfassend imidazolinonsäure
DK1372608T3 (da) Medicinske aerosolformuleringer
BR0209057A (pt) Composições herbicidas contendo benzoilciclohexanodionas e protetores
SE0001899D0 (sv) New compounds
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
ATE437679T1 (de) Wässrige antitranspirant formulierung
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
NZ510509A (en) Compounds that specifically inhibit factor VIIa activity used to inhibit blood clotting and inflammatory response
CR10578A (es) Concentrados no acuosos de principios activos con efecto herbicida
DOP2001000297A (es) Nuevas imidazotriazinonas sustituidas
NO20043661L (no) Bipolare trans-karotenoidsalter og deres anvendelser
SE0302546D0 (sv) New compounds
BR0214299A (pt) Peptìdeo, inibidor de enzima de conversão de angiotensina, e, agente hipotensivo
BRPI0410021A (pt) preparação farmacêutica sólida, que contém sais levotiroxina e/ou liotironina como substáncia ativa
HUP0400520A2 (hu) Klindamicint és cinksót tartalmazó dermatológiai készítmények
TR200100637T2 (tr) Yeni doğal ürün türevleri
EA200701622A1 (ru) Полимерные композиции и их применение для получения композиций активного или эффективного вещества
FR2882522B1 (fr) Composition pharmaceutique solide comprenant de la telithromycine
BR0214524A (pt) 4-cetolactamas e -lactonas 3-bifenil-substituìdas, 3-substituìdas
SE0102910D0 (sv) New use
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
ATE325809T1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure
ATE414538T1 (de) Behandlung zur reduzierung der zunahme des körpergewichts
AR050629A1 (es) Composicion farmaceutica
DE60225587D1 (de) Protease assay zur kontrolle medikamentöser therapie

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]